Van Lanschot Kempen Investment Management N.V. Acquires 806,435 Shares of Avantor, Inc. $AVTR

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Van Lanschot Kempen Investment Management N.V. boosted its holdings in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 17.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,506,019 shares of the company's stock after purchasing an additional 806,435 shares during the period. Avantor makes up approximately 0.9% of Van Lanschot Kempen Investment Management N.V.'s holdings, making the stock its 26th biggest position. Van Lanschot Kempen Investment Management N.V. owned about 0.81% of Avantor worth $89,253,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also added to or reduced their stakes in AVTR. Marshall Wace LLP acquired a new stake in Avantor during the fourth quarter valued at approximately $203,000. Forum Financial Management LP acquired a new stake in shares of Avantor during the fourth quarter valued at approximately $417,000. Dimensional Fund Advisors LP raised its holdings in shares of Avantor by 24.9% during the fourth quarter. Dimensional Fund Advisors LP now owns 6,841,073 shares of the company's stock valued at $144,142,000 after acquiring an additional 1,364,175 shares during the period. MetLife Investment Management LLC raised its holdings in shares of Avantor by 9.2% during the fourth quarter. MetLife Investment Management LLC now owns 383,630 shares of the company's stock valued at $8,083,000 after acquiring an additional 32,282 shares during the period. Finally, Tower Research Capital LLC TRC raised its holdings in shares of Avantor by 23.3% during the fourth quarter. Tower Research Capital LLC TRC now owns 53,914 shares of the company's stock valued at $1,136,000 after acquiring an additional 10,184 shares during the period. 95.08% of the stock is owned by institutional investors and hedge funds.

Avantor Stock Up 5.5%

Avantor stock traded up $0.6950 during trading hours on Friday, hitting $13.2550. The company had a trading volume of 7,756,499 shares, compared to its average volume of 14,265,482. The firm has a market capitalization of $9.04 billion, a P/E ratio of 13.39, a price-to-earnings-growth ratio of 1.50 and a beta of 0.96. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.98 and a quick ratio of 0.67. The firm's fifty day moving average is $13.13 and its 200-day moving average is $14.38. Avantor, Inc. has a fifty-two week low of $10.82 and a fifty-two week high of $27.83.

Avantor (NYSE:AVTR - Get Free Report) last released its quarterly earnings data on Friday, August 1st. The company reported $0.24 earnings per share for the quarter, missing the consensus estimate of $0.25 by ($0.01). The company had revenue of $1.68 billion during the quarter, compared to analyst estimates of $1.67 billion. Avantor had a net margin of 10.31% and a return on equity of 11.39%. The firm's quarterly revenue was down 1.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.25 EPS. On average, research analysts forecast that Avantor, Inc. will post 1.06 earnings per share for the current year.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on AVTR shares. JPMorgan Chase & Co. cut their price target on shares of Avantor from $17.00 to $14.00 and set an "overweight" rating on the stock in a report on Monday, August 4th. Morgan Stanley cut their price target on shares of Avantor from $15.00 to $12.00 and set an "equal weight" rating on the stock in a report on Monday, August 4th. Raymond James Financial set a $14.00 price target on shares of Avantor and gave the company an "outperform" rating in a report on Monday, August 4th. Barclays restated an "overweight" rating and set a $13.00 price target (down previously from $15.00) on shares of Avantor in a report on Monday, August 4th. Finally, Robert W. Baird cut their price target on shares of Avantor from $18.00 to $15.00 and set an "outperform" rating on the stock in a report on Monday, August 4th. Seven equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $15.50.

Insider Buying and Selling

In other Avantor news, CAO Steven W. Eck sold 3,476 shares of the business's stock in a transaction that occurred on Tuesday, August 5th. The shares were sold at an average price of $11.39, for a total value of $39,591.64. Following the completion of the sale, the chief accounting officer directly owned 55,068 shares of the company's stock, valued at $627,224.52. The trade was a 5.94% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 1.20% of the stock is owned by corporate insiders.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.